uridine diphosphate has been researched along with Cranial Nerve II Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, T; Iwata, T; Kashiwagi, K; Koizumi, S; Namekata, K; Ohno, N; Robaye, B; Shinozaki, Y; Takeda, A | 1 |
1 other study(ies) available for uridine diphosphate and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
Topics: Aging; Animals; Aqueous Humor; Ciliary Body; Disease Models, Animal; Dose-Response Relationship, Drug; Glaucoma; Intraocular Pressure; Mice, Knockout; Optic Nerve Diseases; Receptors, Purinergic P2; Retinal Ganglion Cells; Signal Transduction; Uridine Diphosphate | 2017 |